No Data
No Data
Express News | Jupiter Neurosciences Inc - First Three Products Expected to Launch in Q3 2025
Jupiter Neurosciences and Aquanova AG Announce Strategic Collaboration to Develop Longevity and Healthspan Products
Jupiter Neurosciences Says Volatility 'Appears to Be Driven by Misconceptions'
Jupiter Neurosciences Addresses Market Volatility as It Remains Focused on Advancing Clinical and Commercial Milestones
Jupiter Neurosciences Signs Manufacturing Deal With Catalent Pharma for Jotrol Softgel Capsules
Express News | Jupiter Neurosciences- Under Terms, Catalent to Manufacture Clinical Batches of Jotrol for Parkinson's Study